Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Multiple Myeloma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Congenital Abnormalities 6Neoplasms, Plasma Cell 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Acute 5Burkitt Lymphoma 5Sezary Syndrome 4Myeloproliferative Disorders 4Myelodysplastic Syndromes 4Mycosis Fungoides 4Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Extranodal NK-T-Cell 4Lymphoma 4Breast Neoplasms 4Blast Crisis 4Waldenstrom Macroglobulinemia 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3

Interventions

Cisplatin 130Cetuximab 79Radiotherapy 76Docetaxel 58Carboplatin 46pembrolizumab 45Paclitaxel 44Fluorouracil 42Radiotherapy, Intensity-Modulated 35Drug Therapy 17Radiation 14Nivolumab 14Gefitinib 14Gemcitabine 13Surgical Procedures, Operative 12Oxaliplatin 11Erlotinib Hydrochloride 11Pemetrexed 10Celecoxib 10Capecitabine 10Bevacizumab 10130-nm albumin-bound paclitaxel 10tislelizumab 9Filgrastim 9Amifostine 9Albumin-Bound Paclitaxel 9durvalumab 7atezolizumab 7Chemoradiotherapy 7toripalimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Head and Neck Neoplasms × Flow Cytometry × Clear all
NCT00049140 2014-07-25

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

Duke University

Phase 2 Completed
8 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00589186 2013-12-18

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00690872 2009-06-29

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡